Shanghai Junshi Biosciences Co., Ltd. (SHJBF)

1.8600 0.0000 (0.00%) As of 09:51AM EDT. Market open.

Shanghai Junshi Biosciences Co., Ltd.

Building 7
15th Floor No.6, Lane 100, Pingjiaqiao Road Pudong New Area
Shanghai 200126
China
86 21 6105 8800
https://www.junshipharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2,568

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jun Xiong	Executive Chairman	1M	N/A	1974
Mr. Cong Li	Co-CEO & Executive Director	593.5k	N/A	1964
Dr. Jianjun Zou M.D., Ph.D.	GM, CEO & Executive Director	823.51k	N/A	1971
Dr. Ning Li	Executive Vice-Chairman of the Board	1.03M	N/A	1961
Mr. Baohong Xu	Financial Director	N/A	N/A	1979
Mr. Zhuobing Zhang	Deputy GM & Executive Director	947.3k	N/A	1967
Dr. Sheng Yao Ph.D.	Senior VP & Executive Director	651.67k	N/A	1975
Dr. Gang Wang	Deputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director	159.76k	N/A	1957
Ms. Siu Kuen Lai FCIS, FCS	Joint Company Secretary	N/A	N/A	1976
Mr. Zhengyu Wang	Joint Company Secretary	N/A	N/A	1995

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Corporate governance

Shanghai Junshi Biosciences Co., Ltd.’s ISS governance QualityScore as of 1 May 2024 is 8. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.